AMT vs EBS · P/E 31, rev $2.55B vs rev $1.04B
American Tower Corp (AMT) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMT revenue for 2024-12-31 was $2.55B. Net income was $2.28B. Revenue was up 1.0% from 2024-09-30 to 2024-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AMT and EBS stock pages for the full models.
Not investment advice.